Postmastectomy RT decision for lymph node negative patients: Turkish radiation oncology society

Yükleniyor...
Küçük Resim

Tarih

2018

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Elsevier Ireland Ltd

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Early Breast Cancer Trialists’ Collaborative Group meta analyses have shown that postmastectomy radiotherapy (PMRT) had no significant effect on locoregional recurrence (LRR), overall recurrence or breast cancer mortality for patients without lymph node metastases. On the other hand it has also been shown that the risk of developing LRR is rising up to 15% or more for women in the presence of two or more adverse factors even though there is no lymph node involvement. In this study, PMRT indications were evaluated in 12 centers, overall Turkey to observe and document the decision making after mastectomy.

Açıklama

37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) -- APR 20-24, 2018 -- Barcelona, SPAIN
WOS: 000438676100060

Anahtar Kelimeler

Kaynak

37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)

WoS Q Değeri

Q1

Scopus Q Değeri

Cilt

127

Sayı

Supplement: 1

Künye

Altınok, A., Gürsel, B., Ergen, A.., Alanyalı, S., Özsaran, Z., Ay, A. ... Bese, N. (2018). Postmastectomy RT decision for lymph node negative patients: Turkish radiation oncology society. 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) içinde (S696-S697. ss.). Barcelona, Spain, April 20-24 2018. https://dx.doi.org/10.1016/S0167-8140(18)31572-X